Divozilimab (Anti-CD20)Divozilimab (Anti-CD20)
Move your mouse over image or click to enlarge

Divozilimab (Anti-CD20)

Divozilimab (BCD-132) is a humanised monoclonal antibody against CD20 (CD20) with the potential to be used in multiple sclerosis research. MW : 145.26 KD.
Cat# Size Price Qty Buy
A2823-1mg*25 1mg*25
£2,432.00
A2823-1mg*5 1mg*5
£794.00
A2823-1mg 1mg
£303.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2823

Related Documents